Bloodstream Infections Due to Candida Species in the Intensive Care Unit: Identifying Especially High-Risk Patients to Determine Prevention Strategies
Open Access
- 15 September 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement) , S389-S393
- https://doi.org/10.1086/430923
Abstract
Nosocomial bloodstream infections due to Candida species are associated with a 40% crude (total) mortality rate in the United States. The attributablKeywords
This publication has 11 references indexed in Scilit:
- Guidelines for Treatment of CandidiasisClinical Infectious Diseases, 2004
- Epidemiology of Candida species infections in critically ill non-immunosuppressed patientsThe Lancet Infectious Diseases, 2003
- Attributable Mortality of Nosocomial Candidemia, RevisitedClinical Infectious Diseases, 2003
- Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical PatientsAnnals of Surgery, 2001
- Choice of effect measure for epidemiological dataJournal of Clinical Epidemiology, 2000
- The Influence of Inadequate Antimicrobial Treatment of Bloodstream Infections on Patient Outcomes in the ICU SettingChest, 2000
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Risk Factors for Hospital-Acquired CandidemiaArchives of internal medicine (1960), 1989
- Hospital-Acquired CandidemiaArchives of internal medicine (1960), 1988
- Etiologic Organisms as Independent Predictors of Death and Morbidity Associated with Bloodstream InfectionsThe Journal of Infectious Diseases, 1987